Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway G Protein Signaling Small G Proteins Other

Recombinant Human LYPD3 protein (His tag) (ab276436)

Recombinant Human LYPD3 protein (His tag) (ab276436)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Expression system: HEK 293 cells
  • Purity: > 95% SDS-PAGE
  • Endotoxin level:
  • Tags: His tag C-Terminus
  • Suitable for: SDS-PAGE

You may also be interested in

Product image
Anti-Sigma1-receptor antibody [EPR23266-69] - BSA and Azide free (ab273058)
Ipriflavone, Estrogenic synthetic (ab142893)
Product image
Recombinant Mouse Carbonic Anhydrase 12/CA12 protein (His tag) (ab276745)
Product image
Anti-SPARC antibody (ab176975)

Preparation and Storage

  • 2310061G07Rik
  • C4.4A
  • GPI-anchored metastasis-associated protein C4.4A homolog

Images

  • SDS-PAGE - Recombinant Human LYPD3 protein (ab276436)
    SDS-PAGE - Recombinant Human LYPD3 protein (ab276436)
    SDS-PAGE analysis of ab276436

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-PAR4 antibody (ab5787)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.